CS logo
small CS logo
Centre Hospitalier Victor Dupouy

Argenteuil, France
Hôpital à Argenteuil

About Centre Hospitalier Victor Dupouy


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Nantes University Hospital
9
Federation Francophone de Cancerologie Digestive
7
Groupe Francophone des Myelodysplasies
7
The Lymphoma Academic Research Organisation
6
GERCOR - Multidisciplinary Oncology Cooperative Group
5
Versailles Hospital
5
ANRS, Emerging Infectious Diseases
4
Acute Leukemia French Association
4
Celgene
4
Centre Hospitalier Departemental Vendee
4
Groupe Francais De Pneumo-Cancerologie
4
Total Rows: 72

Clinical Trials at Centre Hospitalier Victor Dupouy


During the past decade, Centre Hospitalier Victor Dupouy conducted 89 clinical trials. In the 10-year time frame, 89 clinical trials started and 9 clinical trials were completed, i.e. on average, 10.1% percent of trials that started reached the finish line to date. In the past 5 years, 39 clinical trials started and 5 clinical trials were completed. i.e. 12.8% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years141466121210108816161111101022110011111122111111Started TrialsCompleted Trails20152016201720182019202020212022202301020
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Radiation Therapy in Patients With Limited-Stage Small Cell Lung Cancer in Complete Remission
1999-09-01
2005-12-01
Completed
Gemcitabine and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
1999-09-01
Unknown status
Docetaxel or Paclitaxel in Treating Women With Unresectable Locally Advanced or Metastatic Breast Cancer
2000-05-01
Unknown status
Combination Chemotherapy in Treating Older Women With Metastatic Breast Cancer
2000-01-01
Unknown status
Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas or Bile Duct
1999-01-01
Unknown status
Combination Chemotherapy in Treating Women With Stage I Breast Cancer
2002-08-01
2013-06-01
Completed
1,512
Docetaxel and Epirubicin as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Adenocarcinoma of the Stomach
2001-04-01
Unknown status
Beta-Blocker Continuation Versus Interruption in Heart Failure Worsening
2004-11-01
2009-02-01
Completed
180

Rows per page:

1–100 of 151

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Centre Hospitalier Victor Dupouy" #1 sponsor was "Nantes University Hospital" with 9 trials, followed by "Federation Francophone de Cancerologie Digestive" with 7 trials sponsored, "Groupe Francophone des Myelodysplasies" with 7 trials sponsored, "The Lymphoma Academic Research Organisation" with 6 trials sponsored and "GERCOR - Multidisciplinary Oncology Cooperative Group" with 6 trials sponsored. Other sponsors include 112 different institutions and companies that sponsored additional 72 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hospitalier Victor Dupouy" #1 collaborator was "Ministry of Health, France" with 7 trials as a collaborator, "University Hospital, Tours" with 5 trials as a collaborator, "AstraZeneca" with 3 trials as a collaborator, "Celgene" with 3 trials as a collaborator and "Janssen-Cilag Ltd." with 3 trials as a collaborator. Other collaborators include 92 different institutions and companies that were collaborators in the rest 94 trials.
Created with Highcharts 11.1.0Top Leading SponsorsNantes University Hospital: 9Nantes University Hospital: 9Federation Francophonede CancerologieDigestive: 7Federation Francophonede CancerologieDigestive: 7Groupe Francophonedes Myelodysplasies: 7Groupe Francophonedes Myelodysplasies: 7The LymphomaAcademic ResearchOrganisation: 6The LymphomaAcademic ResearchOrganisation: 6GERCOR -MultidisciplinaryOncology CooperativeGroup: 5GERCOR -MultidisciplinaryOncology CooperativeGroup: 5Versailles Hospital: 5Versailles Hospital: 5ANRS, EmergingInfectious Diseases: 4ANRS, EmergingInfectious Diseases: 4Acute Leukemia FrenchAssociation: 4Acute Leukemia FrenchAssociation: 4Celgene: 4Celgene: 4Centre HospitalierDepartemental Vendee:4Centre HospitalierDepartemental Vendee:4

Created with Highcharts 11.1.0Top CollaboratorsMinistry of Health, France: 7Ministry of Health, France: 7University Hospital, Tours: 5University Hospital, Tours: 5AstraZeneca: 3AstraZeneca: 3Celgene: 3Celgene: 3Janssen-Cilag Ltd.: 3Janssen-Cilag Ltd.: 3Assistance Publique -Hôpitaux de Paris: 2Assistance Publique -Hôpitaux de Paris: 2Association CliniqueThérapeutique Infantiledu val de Marne: 2Association CliniqueThérapeutique Infantiledu val de Marne: 2Bristol-Myers Squibb: 2Bristol-Myers Squibb: 2Celgene Corporation: 2Celgene Corporation: 2Groupe Francais DePneumo-Cancerologie:2Groupe Francais DePneumo-Cancerologie:2

Clinical Trials Conditions at Centre Hospitalier Victor Dupouy


According to Clinical.Site data, the most researched conditions in "Centre Hospitalier Victor Dupouy" are "Multiple Myeloma" (9 trials), "COVID-19" (6 trials), "Acute Myeloid Leukemia" (5 trials), "Breast Cancer" (5 trials) and "Covid19" (4 trials). Many other conditions were trialed in "Centre Hospitalier Victor Dupouy" in a lesser frequency.

Clinical Trials Intervention Types at Centre Hospitalier Victor Dupouy


Most popular intervention types in "Centre Hospitalier Victor Dupouy" are "Drug" (87 trials), "Other" (32 trials), "Procedure" (12 trials), "Device" (9 trials) and "Biological" (6 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (14 trials), "Cyclophosphamide" (5 trials), "Rituximab" (4 trials), "Endotracheal tubes allowing SSD" (3 trials) and "Endotracheal tubes not allowing SSD" (3 trials). Other intervention names were less common.

Clinical Trials Genders at Centre Hospitalier Victor Dupouy


The vast majority of trials in "Centre Hospitalier Victor Dupouy" are 141 trials for "All" genders, 9 trials for "Female" genders and 1 trials for "Male" genders.

Clinical Trials Status at Centre Hospitalier Victor Dupouy


Currently, there are NaN active trials in "Centre Hospitalier Victor Dupouy". undefined are not yet recruiting, 27 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 81 completed trials in Centre Hospitalier Victor Dupouy, 1 suspended trials, and 12 terminated clinical trials to date.
Out of the total trials that were conducted in Centre Hospitalier Victor Dupouy, 6 "Phase 1" clinical trials were conducted, 40 "Phase 2" clinical trials and 43 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 29 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 43Phase 3: 43Phase 2: 40Phase 2: 40Not Applicable: 29Not Applicable: 29Phase 1: 6Phase 1: 6Phase 4: 5Phase 4: 5

Created with Highcharts 11.1.0Trials StatusCompleted: 81Completed: 81Recruiting: 27Recruiting: 27Active, not recruiting: 14Active, not recruiting: 14Unknown status: 14Unknown status: 14Terminated: 12Terminated: 12Withdrawn: 2Withdrawn: 2Suspended: 1Suspended: 1

Departments of Centre Hospitalier Victor Dupouy


Centre Hospitalier Victor Dupouy has several departments that took part in Clinical trials: "CH Argenteuil - Service de Réanimation" - 2 trials
Departments List
Total Rows: 1